Venlafaxine Tablet, Coated
Product Images NDC 71209-088

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Venlafaxine (NDC 71209-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cont-label-150mg-1000-tab (Cont Label 150mg 1000 Tab)

This is a medication description for Venlafaxine Extended-Release Tablets, each containing 150mg of Venlafaxine Hydrochloride USP in extended-release formulation. The recommended dosage is once daily, and the medication needs to be protected from moisture and humidity, as well as kept away from children. The medicine has to be dispensed in a tight container, and patients need to receive the accompanying medication guide. The manufacturing company of the medication is Cadila Pharmaceuticals LTD, from Gujarat State, India.*

FDA Label Image

Cont-label-150mg-30-tab (Cont Label 150mg 30 Tab)

This is a medication label for Venlafaxine Extended-Release Tablets. The tablet contains Venlafaxine and is used for once-daily dosage. The medication should be stored between 20-25 degrees Celsius and protected from moisture and humidity. The label also includes manufacturer details, dosage instructions, and precautionary warnings.*

FDA Label Image

Cont-label-150mg-90-tab (Cont Label 150mg 90 Tab)

This is a medication description for extended-release Venlafaxine Hydrochloride tablets. Each tablet contains 150 mg of Venlafaxine in extended-release formulation. The NDC number is 71209-088-04, and it should be stored between 20° to 25°C (68°to 77°F). The recommended usual dosage is once daily. This medication should be kept in a tightly closed container and protected from moisture and humidity. The manufacturer is Cadila Pharmaceuticals Ltd. The medication comes in a pack with 90 tablets and a size of 100 x 40 mm - Sticker Label. Advise the patients to read the medication guide before use.*

FDA Label Image

Cont-label-225mg-1000-tab (Cont Label 225mg 1000 Tab)

Each tablet contains 225mg of venlafaxine hydrochloride USP in an extended-release formulation. The tablet should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with humidity protection. The usual dosage is once a day, and the medication should be kept out of the reach of children in a tightly closed, child-resistant container. Manufactured by Cadila Pharmaceuticals Ltd. in India, the tablets are dispensed with a medication guide for each patient. There is additional information on the label regarding batch coding and size.*

FDA Label Image

Cont-label-225mg-30-tab (Cont Label 225mg 30 Tab)

Each tablet of this medication contains 225 mg of Venlafaxine in an extended-release form. It should be stored in a dry place between 20°C and 25°C, with permissible temperature excursions between 15°C to 30°C. The usual dosage is once a day, and it must be kept out of the reach of children. The medicine has been manufactured by Cadila Pharmaceuticals Ltd. in India, and it comes with a medication guide that must be dispensed by the pharmacist to the patient.*

FDA Label Image

Cont-label-225mg-90-tab (Cont Label 225mg 90 Tab)

This text is a description of a medication called Venlafaxine Extended-Release Tablets. It indicates that each tablet contains 225mg of the active ingredient Venlafadne hydrochiorde USP in an extended-release formula. The medication should be stored at room temperature and protected from moisture and humidity. The usual dosage is once a day, as indicated in the package insert, and should be dispensed in a container with a child-resistant closure. The manufacturer is Cadila Pharmaceuticals Ltd, located in Gujarat State, India. The text also includes a medication guide that should be provided to each patient by the pharmacist.*

FDA Label Image

Cont-label-75mg-1000-tab (Cont Label 75mg 1000 Tab)

This is a medication label for Venlafaxine extended-release tablets. Each tablet contains 75mg of Venlafaxine hydrochloride USP. The tablets should be stored between 20°C to 25°C and protected from moisture and humidity. The usual dosage is once daily, and the tablets should be dispensed in a tight container with a child-resistant closure. The manufacturer of the medication is Cadila Pharmaceuticals Ltd. from Gujarat State, India. The label includes a medication guide to be provided to each patient by the pharmacist. The size of the label is 160 x 60 mm.*

FDA Label Image

Cont-label-75mg-30-tab (Cont Label 75mg 30 Tab)

This is a medication called Ezch tablet that contains 75mg of venlafaxine hydrochloride in an extended-release formulation. It comes in a tight container with child-resistant closure and should be stored at 20° to 25°C. The usual dosage is once daily as prescribed by a doctor. The medication guide should be dispensed to each patient, and it is important to keep it and all medications out of reach of children. This medication is manufactured by Cadila Pharmaceuticals LTD in India.*

FDA Label Image

Cont-label-75mg-90-tab (Cont Label 75mg 90 Tab)

Each tablet contains 75mg of venlafaxine in an extended-release formulation. The tablets should be stored at a temperature between 20-25°C and protected from moisture and humidity. The medication should be dispensed in a tight container with a child-resistant closure and kept out of reach of children. The usual dosage is once daily; refer to the package insert for prescription information. The medication is manufactured by Cadila Pharmaceuticals Ltd. in India and is dispensed with a medication guide for each patient. The label size is 100 x 40 mm.*

FDA Label Image

Venlafaxine-spl-strc. (Venlafaxine Spl Strc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.